spacer
home > pmps > winter 2001 > editor's letter
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Editor's Letter

This year has been a milestone - the first year of the millennium has been overshadowed by the tragic events of September 11th, followed by the war in Afghanistan. These events have had their impact on our industry in at least two ways. Firstly, many visitors and exhibitors to the events planned in October were unable to travel. As a result, for our US colleagues in particular, planned meetings didn't happen.

Nevertheless, it was interesting to see many of the European and Asia Pacific contract pharmaceutical manufacturers and suppliers at the CPhI in London. Secondly, the increased threat of bioterrorism focused the minds of pharma and biotech players and their investors in the scramble for dwindling stocks of antibiotics effective against anthrax, while orders for the

smallpox vaccine by the US government have been of benefit to UK suppliers. In the biotech sector, companies may be looking further ahead to anticipate their leading edge technologies being overtaken. Formation of alliances, partnerships or M&As could be part of a defensive strategy.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Along with our sister publications, EBR and EPC, this issue of PMPS is published by our new owners Samedan Ltd. PMPS Winter 2001 aims to provide interesting reading over the festive season.
spacer
Dr Patricia Lobo
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement